Clearwater International advises Prime Technology Ventures on the sale of Human inference to GIMV and Iris Capital

Clearwater International has advised Prime Technology Ventures, a leading early-stage venture capital firm, on the sale of Human Inference, a European market leader in the field of data quality solutions, to GIMV and Iris Capital.

Prime Technology Ventures has divested its majority shareholding in Human Inference to GIMV in Belgium and Iris Capital in France. The new shareholders intend to support the company with its international expansion. Prime Technology Ventures has been a shareholder of Human Inference since the 2003 MBO.

Human Inference provides solutions that optimise the quality of contact data, substantially improving interactions between organisations and customers. The software is based on natural language processing that incorporates country-specific knowledge. Prime Technology Ventures focuses on investing in European companies within information technology and related industries. The firm leverages capital, experience, and contacts to actively guide their portfolio companies to global category leaders.